Fig. 1 · Structure
Documents & Downloads
CBP/p300-IN-1
Epigenetic Reader Domain Inhibitor
CBP/p300-IN-1 is an inhibitor targeting the bromodomain of CBP and EP300, key epigenetic reader domains. This compound disrupts the interaction between bromodomains and acetylated lysines, thereby modulating gene expression and influencing cellular processes. Its research applications include studies on transcriptional regulation, cancer biology, and the development of epigenetic therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2443789-32-8 |
| Applications | Epigenetic Reader Domain Inhibitor |
| Formula | C23H23FN2O5 |
| Molecular Weight | 426.44 |
| SMILES | CC(N1C2=CC=C(OC)C=C2C(C(NC3=C(F)C=CC(C(OC(C)(C)C)=O)=C3)=O)=C1)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.